Category Archives: Health Care Services

Creatinine Measurement Market: Commercialization of Advanced Testing Methods

The Creatinine Measurement Market is expected to reach USD 700.8 million by 2027 from USD 377.2 million in 2018, at a CAGR of 8.4%.

The increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, growing awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rising geriatric population, and increasing number of drug development initiatives are the key drivers for ****** creatinine measurement market.

The Jaffe’s kinetic method segment is expected to hold the largest in the market in 2018

Orphan Drugs Market Overview, Trends, Opportunities, Growth and Forecast to 2020-2025

According to IMARC Group’s latest report, titled “Orphan Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the ****** orphan drugs market to exhibit moderate growth during the next five years.

Orphan drugs are used to diagnose, prevent, and treat rare medical disorders. These drugs aim to meet particular public health requirements and generally have a limited production, only for a small group of patients. Orphan drugs help in treating several oncological, metabolic, hematologic, immunologic, infectious, and neurological ailments. These ailments majorly include lymphoma, leukemia, cystic fibrosis, glioma, pancreatic cancer, ovarian cancer, etc.

Cerebrospinal Fluid Management Market: Complications Related to CSF Shunts

The ****** cerebrospinal fluid (CSF) management market is expected to reach USD 1.56 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 4.4%.

The key factors driving the growth of cerebrospinal fluid management market include the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population.

By product, the shunts segment held the largest share of the market in 2017

****** Transplant Diagnostics Market : Increasing Prevalence of Infectious Diseases’

According to the new market research report Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) – ****** Forecast to 2025″, published by MarketsandMarkets™, the Transplant Diagnostics Market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.

Download PDF Brochure:

The demand for transplant diagnostic products is expected to grow mainly due to factors such as technological advancements, the growing number of diagnostic centers & hospitals, increased applications in patient profiling, and rising public-private investments to support product development. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities-especially in emerging markets, which are expected to witness the highest growth.

Blood Group Typing Market: Growing Demand In Forensic Science Worth $3.12 Billion

According to a new market research report “Blood Group Typing Market by Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User – ****** Forecast to 2021” published by MarketsandMarkets™, the blood typing market is projected to reach USD 3.12 Billion by 2021 from USD 1.95 Billion in 2016, at a CAGR of 9.8%.

Browse 68 market data Tables and 69 Figures spread through 146 Pages and in-depth TOC on “Blood Group Typing Market

Downstream Processing Market In Biopharmaceuticals To Reach $22.03 Billion

According to a new market research report “Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) – ****** Forecast to 2021“, published by MarketsandMarkets, the ****** market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021.

Browse 68 market data Tables and 40 Figures spread through 139 Pages and in-depth TOC on “Downstream Processing Market

GCC Diagnostic Imaging Market by Product, Type, Application and Regional Forecast to 2020

Bharat Book Bureau Provides the Trending Market Research Report on “GCC Diagnostic Imaging Market Analysis, 2020” under Medical Devices category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.

Diagnostic Imaging, also known as Medical Imaging, is the technique of creating visual representations of the interiors of a body for clinical analysis and medical intervention, as well as visual representation of the functions of some organs or tissues.

GCC Diagnostic Imaging Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of GCC Diagnostic Imaging market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

Venipuncture Procedure Analysis: Growing Demand For Venipuncture Needles and Syringes

Venipuncture is the process of Blood Collection through venous access. This can be done by intravenous cannulation. The total venipuncture procedure includes the total number of cannulations performed, including successful and unsuccessful cannulation.

According to a new market research report “Venipuncture Procedure Analysis by Success Rate (Total Venipuncture, Successful Venipuncture), Vein Type (Cephalic Vein, Median Cubital Vein, Basilic Vein), End Users (Hospitals (Private), Diagnostic Labs, Physicians Offices) – ****** Forecast to 2021” published by MarketsandMarkets, the market is projected to reach USD 1,044.6 Million by 2021 from USD 790.8 Million in 2016, at a CAGR of 5.7% during the forecast period.

Insomnia Market: High Demand For OTC Sleep Aids In US Region Worth $4.24 Billion

According to a new market research report “US Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) – Forecasts to 2021“, published by MarketsandMarkets, the insomnia therapeutics market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, at a CAGR of 4.6% during the forecast period.

This growth in insomnia therapeutics market can be attributed to the launch of new drugs for the treatment of insomnia and government support to control rising insomnia cost. However, due to the erosion in branded drugs sales and growing adoption of generics attributed to their low cost and equal efficacy as compared to branded products may hinder the growth of the US Insomnia Market.